文献速递食管胃疾病与幽门螺杆菌

幽门螺杆菌阴性胃炎的临床表现

Clinical Manifestations of Helicobacter pylori-Negative Gastritis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-01-18

在单一退伍军人医疗中心开展横断面研究,1240例有完整活检部位信息的患者中695例(56.0%)患胃炎,幽门螺杆菌阴性胃炎占全部受试者的9.9%、占胃炎患者的17.7%;非西班牙裔白人比非裔美国人更易患幽门螺杆菌阴性胃炎,质子泵抑制剂使用者更易患幽门螺杆菌阴性胃炎而非幽门螺杆菌阳性胃炎。

要点

  • 幽门螺杆菌阴性胃炎占全部受试者的9.9%、占胃炎患者的17.7%。
  • 非裔美国人较非西班牙裔白人发生幽门螺杆菌阴性胃炎的比值比为0.25(95%CI 0.14-0.43)。
  • 质子泵抑制剂使用者较非使用者发生幽门螺杆菌阴性胃炎(相对于幽门螺杆菌阳性胃炎)的比值比为2.02(95%CI 1.17-3.49)。

核心结论

  • 幽门螺杆菌阴性胃炎存在于约18%的胃炎患者中。
  • 幽门螺杆菌阴性胃炎进展的潜在可能以及胃黏膜萎缩/肠化生患者的胃癌风险仍不明确。

研究设计与样本

  • 在单一退伍军人医疗中心开展的横断面研究,纳入计划择期食管胃十二指肠镜检查或就诊于选定初级保健诊所并有资格接受筛查性结肠镜检查的患者。
  • 共1240例患者具有所有活检部位的信息。
  • 胃炎定义为存在中性粒细胞和/或单核细胞。

主要发现

  • 1240例患者中695例(56.0%)患胃炎。
  • 幽门螺杆菌阴性胃炎存在于123例患者中,占全部研究对象的9.9%、占全部胃炎患者的17.7%。
  • 在全部胃炎患者中,非裔美国人较非西班牙裔白人发生幽门螺杆菌阴性胃炎的比值比为0.25(95%CI 0.14-0.43)。
  • 质子泵抑制剂使用者较非使用者发生幽门螺杆菌阴性胃炎(相对于幽门螺杆菌阳性胃炎)的比值比为2.02(95%CI 1.17-3.49)。
  • 幽门螺杆菌阴性胃炎患者的胃糜烂和溃疡累积发生率高于幽门螺杆菌阴性无胃炎患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: There are data to suggest the existence of non-Helicobacter pylori gastritis. However, the risk factors and clinical course for H pylori-negative gastritis remain unclear. We aimed to examine the prevalence and determinants of H pylori-negative gastritis in a large multiethnic clinical population. METHODS: We conducted a cross-sectional study among patents scheduled for an elective esophagastroduodenoscopy or attending selected primary care clinics and eligible for screening colonoscopy at a single Veterans Affairs medical center. We identified cases of H pylor-negative gastritis, H pylori-positive gastritis, and H pylori-negative nongastritis, where gastritis was defined by the presence of neutrophils and/or mononuclear cells. Risk factors for H pylori-negative gastritis were analyzed in logistic regression models. RESULTS: A total of 1240 patients had information from all biopsy sites, of whom 695 (56.0%) had gastritis. H pylori-negative gastritis was present in 123 patients (9.9% of all study subjects and 17.7% of all patients with gastritis). Among all patients with gastritis, African Americans were statistically significantly less likely than non-Hispanic whites to have H pylori-negative gastritis (odds ratio, 0.25; 95% confidence interval, 0.14-0.43). Conversely, PPI users were more likely to have H pylori-negative gastritis than H pylori-positive gastritis compared with nonusers (odds ratio, 2.02; 95% confidence interval, 1.17-3.49). The cumulative incidence of gastric erosions and ulcers were higher in patients with H pylori-negative gastritis than H pylori-negative nongastritis. CONCLUSIONS: We found that H pylori-negative gastritis was present in approximately 18% of patients with gastritis. The potential for H pylori-negative gastritis to progress or the risk of gastric cancer of those with gastric mucosal atrophy/intestinal metaplasia remains unclear.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Shiota S, Thrift AP, Green L, et al. Clinical Manifestations of Helicobacter pylori-Negative Gastritis. Clin Gastroenterol Hepatol. 2017. PMID: 28110098. doi:10.1016/j.cgh.2017.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。